Neuphoria Therapeutics Inc.
-
Ticker
NEUP
-
Industry
Biotechnology More
-
Sector
Healthcare More
- 11-50 Employees
- Based in Burlington, Massachusetts
Neuphoria Therapeutics dedicated to pioneering breakthrough therapies that address the complex needs of individuals affected by neuropsychiatric disorders. By focusing on novel approaches and advancing scientific understanding, they aim to deliver medicines that offer lasting relief and hope for a brighter, healthier future.
REPORT RATINGS
4.7 / 5.0 (82)
Neuphoria Therapeutics Inc. reports have an aggregate usefulness score of 4.7 based on 82 reviews.
Neuphoria Therapeutics Inc.
Most Recent Annual Report
MOST RECENT
2024 Annual Report
Older/Archived Annual Reports